Shares of Tilray Inc (NASDAQ:TLRY – Get Free Report) traded down 1.5% on Wednesday . The stock traded as low as $1.62 and last traded at $1.63. 8,519,988 shares traded hands during mid-day trading, a decline of 66% from the average session volume of 25,141,068 shares. The stock had previously closed at $1.65.
Tilray Stock Down 0.9 %
The company has a 50 day moving average price of $1.77 and a two-hundred day moving average price of $1.87. The company has a debt-to-equity ratio of 0.10, a current ratio of 2.27 and a quick ratio of 1.42. The stock has a market cap of $1.27 billion, a PE ratio of -3.72 and a beta of 2.13.
Tilray (NASDAQ:TLRY – Get Free Report) last posted its quarterly earnings results on Monday, July 29th. The company reported ($0.04) earnings per share for the quarter, missing the consensus estimate of ($0.02) by ($0.02). Tilray had a negative return on equity of 2.63% and a negative net margin of 30.26%. The business had revenue of $229.90 million during the quarter, compared to analysts’ expectations of $226.20 million. During the same quarter in the prior year, the firm earned ($0.15) EPS. The firm’s revenue for the quarter was up 24.8% compared to the same quarter last year. Analysts expect that Tilray Inc will post -0.16 EPS for the current year.
Institutional Inflows and Outflows
About Tilray
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
See Also
- Five stocks we like better than Tilray
- What is the Shanghai Stock Exchange Composite Index?
- 3 Momentum Trades for October With Ample Upside Ahead
- Manufacturing Stocks Investing
- Roblox Dips on Short Report—Here’s Why It Could Bounce Back Fast
- Following Congress Stock Trades
- 2 Reasons to Jump on Apple Stock Now and 1 Reason to Think Twice
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.